OA

Odesangel AB

Europe, Stockholms Lan, Sweden, Stockholm

Description

Odesangel AB

Investor Profile

Odesangel AB has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Convertible Note rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Artificial Intelligence (AI), Biotechnology, Genetics.

Stage Focus

  • Convertible Note (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Artificial Intelligence (Ai)
  • Biotechnology
  • Genetics
  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Odesangel AB frequently co-invest with?

Shared Deals: 1
Starlight Ventures
North America, Florida, United States, Miami
Shared Deals: 1
FT
Europe, Gullbringusysla, Iceland, Reykjavík
Shared Deals: 1
IL
North America, California, United States, San Francisco
Shared Deals: 1
AF
North America, California, United States, San Francisco
Shared Deals: 1
VH
Europe, Southern Finland, Finland, Espoo
Shared Deals: 1

Which angels does Odesangel AB often collaborate with?

Shared Deals: 1
Shared Deals: 1

What are some of recent deals done by Odesangel AB?

HelixNano

Cambridge, Massachusetts, United States

Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases.

Artificial Intelligence (AI)BiotechnologyGeneticsHealth Care
Convertible NoteMar 16, 2020
Amount Raised: $1,110,000